医药大省宣布:所有药房托管 立即停止

2019-02-12 赛柏蓝—玉米 江苏省卫健委

药房托管,立即停止!江苏所有公立医院,立即停止药房托管日前,江苏省卫健委和江苏省中医药管理局发布《关于全面停止公立医疗机构药房托管的通知(苏卫医政〔2019〕9号)》(以下简称《通知》)。要求 江苏省所有公立医疗机构,不得承包、出租药房,不得向企业托管药房或与企业开展类似业务合作 。 已经托管、变相托管的,立即停止!实际上,关于叫停公立医疗机构的药房托管, 2018年11月26日国家卫健委、中医药

药房托管,立即停止!

江苏所有公立医院,立即停止药房托管

日前,江苏省卫健委和江苏省中医药管理局发布《关于全面停止公立医疗机构药房托管的通知(苏卫医政〔2019〕9号)》(以下简称《通知》)。

要求 江苏省所有公立医疗机构,不得承包、出租药房,不得向企业托管药房或与企业开展类似业务合作 。 已经托管、变相托管的,立即停止!

实际上,关于叫停公立医疗机构的药房托管, 2018年11月26日国家卫健委、中医药管理局发布的《关于加快药学服务高质量发展的意见(国卫医发〔2018〕45号)》里,明确“坚持公立医院药房的公益性,公立医院不得承包、出租药房,不得向营利性企业托管药房”,一锤定音。

不得以药品供应延伸服务,变相托管

在《通知》中,江苏要求,在药房供应链优化过程中, 不得以药品供应延伸服务方式变相托管药房 ,切实切断医疗机构及医务人员与企业的利益关系,确保公立医疗机构对药房人、财、物的经营自主权和管理权。

《通知》表示, 已经实行药房托管、变相托管的公立医疗机构应立即停止托管、变相托管行为 ,并妥善做好停止托管后的药品供应保障衔接工作。

顺便说一句,以“以药品供应延伸服务”为名,行“托管药房”之实的操作模式,屡见于一些上市药企、药商的年报和公告中。江苏还要求,针对公立医疗机构药房托管情况开展专项排查,并上报江苏卫健委医政医管处。

托管不赚钱,还有政策风险

正如上文所述,在国家卫健委、中医药管理局叫停公立医院药房托管后,北京市卫健委跟进,发文要求公立医疗机构要坚持公益性,坚决杜绝公立医院承包、出租药房,或者向盈利性企业托管药房。

此前,上海也曾明确公立医院“不应与有关企业开展药房‘托管’或类似业务合作”;又如青海、山东、广东、湖北等省份都出台了相关文件,规范或禁止药房托管。

其实,早在去年6月,就有大型药商说“托管不赚钱,还有政策风险”;九州通和步长联手的美好愿望,由托管药房,改为转战院边店。现在回头看看,就托管这个事,还是大型企业有前瞻性。

历经17年,退出历史舞台

行业公认的说法,药房托管现象始于2001年。从2005年到2018年,13年中,经历了“星星之火”到“熊熊燎原”的变迁,但也就是在2018年,这个模式被摁下“停止”键。

这个模式,或许有其良好的初衷,但其一路发展伴随的“涉嫌垄断”“怪胎”的争议,以及切不断的利益链、和真正医药分家的改革目标相去甚远的落点,叫停是必然。

实际上,不太符合事物发展规律,不符合行业发展方向的一些现象,经历一段时间后,都会退出历史舞台。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1654335, encodeId=e130165433578, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Mon Dec 23 16:43:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691240, encodeId=8c6916912406b, content=<a href='/topic/show?id=8b968e5822e' target=_blank style='color:#2F92EE;'>#药房托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87582, encryptionId=8b968e5822e, topicName=药房托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=270129200363, createdName=陈吴1244, createdTime=Sat Jun 22 11:43:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035585, encodeId=17452035585fe, content=<a href='/topic/show?id=e7c5353259d' target=_blank style='color:#2F92EE;'>#医药大省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35325, encryptionId=e7c5353259d, topicName=医药大省)], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160723/IMG57937A3BB59F33185.jpg, createdBy=7642322, createdName=手留余香, createdTime=Fri Oct 18 05:43:00 CST 2019, time=2019-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409789, encodeId=6e631409e8920, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Feb 14 04:43:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604410, encodeId=a164160441087, content=<a href='/topic/show?id=408e5468454' target=_blank style='color:#2F92EE;'>#托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54684, encryptionId=408e5468454, topicName=托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c4f19182763, createdName=spoonycyy, createdTime=Thu Feb 14 04:43:00 CST 2019, time=2019-02-14, status=1, ipAttribution=)]
    2019-12-23 sunmin0227
  2. [GetPortalCommentsPageByObjectIdResponse(id=1654335, encodeId=e130165433578, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Mon Dec 23 16:43:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691240, encodeId=8c6916912406b, content=<a href='/topic/show?id=8b968e5822e' target=_blank style='color:#2F92EE;'>#药房托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87582, encryptionId=8b968e5822e, topicName=药房托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=270129200363, createdName=陈吴1244, createdTime=Sat Jun 22 11:43:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035585, encodeId=17452035585fe, content=<a href='/topic/show?id=e7c5353259d' target=_blank style='color:#2F92EE;'>#医药大省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35325, encryptionId=e7c5353259d, topicName=医药大省)], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160723/IMG57937A3BB59F33185.jpg, createdBy=7642322, createdName=手留余香, createdTime=Fri Oct 18 05:43:00 CST 2019, time=2019-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409789, encodeId=6e631409e8920, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Feb 14 04:43:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604410, encodeId=a164160441087, content=<a href='/topic/show?id=408e5468454' target=_blank style='color:#2F92EE;'>#托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54684, encryptionId=408e5468454, topicName=托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c4f19182763, createdName=spoonycyy, createdTime=Thu Feb 14 04:43:00 CST 2019, time=2019-02-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1654335, encodeId=e130165433578, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Mon Dec 23 16:43:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691240, encodeId=8c6916912406b, content=<a href='/topic/show?id=8b968e5822e' target=_blank style='color:#2F92EE;'>#药房托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87582, encryptionId=8b968e5822e, topicName=药房托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=270129200363, createdName=陈吴1244, createdTime=Sat Jun 22 11:43:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035585, encodeId=17452035585fe, content=<a href='/topic/show?id=e7c5353259d' target=_blank style='color:#2F92EE;'>#医药大省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35325, encryptionId=e7c5353259d, topicName=医药大省)], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160723/IMG57937A3BB59F33185.jpg, createdBy=7642322, createdName=手留余香, createdTime=Fri Oct 18 05:43:00 CST 2019, time=2019-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409789, encodeId=6e631409e8920, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Feb 14 04:43:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604410, encodeId=a164160441087, content=<a href='/topic/show?id=408e5468454' target=_blank style='color:#2F92EE;'>#托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54684, encryptionId=408e5468454, topicName=托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c4f19182763, createdName=spoonycyy, createdTime=Thu Feb 14 04:43:00 CST 2019, time=2019-02-14, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1654335, encodeId=e130165433578, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Mon Dec 23 16:43:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691240, encodeId=8c6916912406b, content=<a href='/topic/show?id=8b968e5822e' target=_blank style='color:#2F92EE;'>#药房托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87582, encryptionId=8b968e5822e, topicName=药房托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=270129200363, createdName=陈吴1244, createdTime=Sat Jun 22 11:43:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035585, encodeId=17452035585fe, content=<a href='/topic/show?id=e7c5353259d' target=_blank style='color:#2F92EE;'>#医药大省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35325, encryptionId=e7c5353259d, topicName=医药大省)], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160723/IMG57937A3BB59F33185.jpg, createdBy=7642322, createdName=手留余香, createdTime=Fri Oct 18 05:43:00 CST 2019, time=2019-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409789, encodeId=6e631409e8920, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Feb 14 04:43:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604410, encodeId=a164160441087, content=<a href='/topic/show?id=408e5468454' target=_blank style='color:#2F92EE;'>#托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54684, encryptionId=408e5468454, topicName=托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c4f19182763, createdName=spoonycyy, createdTime=Thu Feb 14 04:43:00 CST 2019, time=2019-02-14, status=1, ipAttribution=)]
    2019-02-14 cathymary
  5. [GetPortalCommentsPageByObjectIdResponse(id=1654335, encodeId=e130165433578, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Mon Dec 23 16:43:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691240, encodeId=8c6916912406b, content=<a href='/topic/show?id=8b968e5822e' target=_blank style='color:#2F92EE;'>#药房托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87582, encryptionId=8b968e5822e, topicName=药房托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=270129200363, createdName=陈吴1244, createdTime=Sat Jun 22 11:43:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035585, encodeId=17452035585fe, content=<a href='/topic/show?id=e7c5353259d' target=_blank style='color:#2F92EE;'>#医药大省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35325, encryptionId=e7c5353259d, topicName=医药大省)], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160723/IMG57937A3BB59F33185.jpg, createdBy=7642322, createdName=手留余香, createdTime=Fri Oct 18 05:43:00 CST 2019, time=2019-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409789, encodeId=6e631409e8920, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Feb 14 04:43:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604410, encodeId=a164160441087, content=<a href='/topic/show?id=408e5468454' target=_blank style='color:#2F92EE;'>#托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54684, encryptionId=408e5468454, topicName=托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c4f19182763, createdName=spoonycyy, createdTime=Thu Feb 14 04:43:00 CST 2019, time=2019-02-14, status=1, ipAttribution=)]
    2019-02-14 spoonycyy